Page 33 - MI-2-3
P. 33

Microbes & Immunity                                                    Correlation between VZV and cancer



            and cell survival, may help clarify potential connections   2.   Arvin AM. Creating the “dew drop on a rose petal”: The
            between the virus and tumorigenesis. Understanding how   molecular pathogenesis of varicella-zoster virus skin lesions.
            VZV manipulates host cell functions – such as inhibiting   Microbiol Mol Biol Rev. 2023;87(3):e0011622.
            apoptosis or altering cell cycle regulation – could shed      doi: 10.1128/mmbr.00116-22
            light on how normal cells might transform into cancerous   3.   Kennedy PG, Mogensen TH. Determinants of neurological
            ones. These insights are crucial in determining whether   syndromes  caused by  varicella  zoster  virus  (VZV).
            VZV is merely a viral pathogen or if it could also act as   J Neurovirol. 2020;26(4):482-495.
            an oncogenic factor, contributing to cancer development      doi: 10.1007/s13365-020-00857-w
            in certain cells or conditions, similar to other viruses in the
            Herpesviridae family.                              4.   Eshleman E, Shahzad A, Cohrs RJ. Varicella zoster virus
                                                                  latency. Future Virol. 2011;6(3):341-355.
            Acknowledgments                                       doi: 10.2217/fvl.10.90
            None.                                              5.   Kennedy PGE, Gershon AA. Clinical features of varicella-
                                                                  zoster virus infection. Viruses. 2018;10(11):609.
            Funding
                                                                  doi: 10.3390/v10110609
            None.
                                                               6.   Jones D, Como CN, Jing L,  et al. Varicella zoster virus
            Conflict of interest                                  productively infects human peripheral blood mononuclear
                                                                  cells to modulate expression of immunoinhibitory proteins
            Shizue Mito is the Youth Editorial Board Member of this   and blocking PD-L1 enhances virus-specific CD8+ T cell
            journal but was not in any way involved in the editorial   effector function. PLoS Pathog. 2019;15(3):e1007650.
            and peer-review process conducted for this paper, directly      doi: 10.1371/journal.ppat.1007650
            or indirectly. Separately, other authors declared that they   7.   Wyburn-Mason R.  Malignant change  arising  in  tissues
            have no known competing financial interests or personal   affected by herpes. Br Med J. 1955;2(4948):1106-1109.
            relationships that could have influenced the work reported
            in this paper.                                        doi: 10.1136/bmj.2.4948.1106
                                                               8.   Sorel O, Messaoudi I. Insights into the pathogenesis of
            Author contributions                                  varicella viruses. Curr Clin Microbiol Rep. 2019;6(3):156-165.
            Conceptualization: Fernando Cisneros IV, Blake Martin     doi: 10.1007/s40588-019-00119-2
            Supervision: Shizue Mito                           9.   Wrensch M, Weinberg A, Wiencke J,  et al. History of
            Visualization: Fernando Cisneros IV                   chickenpox and shingles and prevalence of antibodies
            Writing – original draft:  Fernando Cisneros IV, Blake   to varicella-zoster virus and three other herpesviruses
               Martin                                             among adults with glioma and controls.  Am J Epidemiol.
            Writing – review & editing: Fernando Cisneros IV, Shizue   2005;161(10):929-938.
               Mito                                               doi: 10.1093/aje/kwi119

            Ethics approval and consent to participate         10.  Multhoff G, Molls M, Radons J. Chronic inflammation in
                                                                  cancer development. Front Immunol. 2011;2:98.
            Not applicable.
                                                                  doi: 10.3389/fimmu.2011.00098
            Consent for publication                            11.  Cotton SJ, Belcher J, Rose P, Jagadeesan SK, Neal RD.
                                                                  The risk of a subsequent cancer diagnosis after herpes
            Not applicable.                                       zoster infection: Primary care database study. Br J Cancer.

            Availability of data                                  2013;108(3):721-726.
                                                                  doi: 10.1038/bjc.2013.13
            Not applicable.
                                                               12.  Fueyo MA, Lookingbill DP. Herpes zoster and occult
            References                                            malignancy. J Am Acad Dermatol. 1984;11(3):480-482.
            1.   Gershon AA, Gershon MD, Breuer J, Levin MJ,      doi: 10.1016/s0190-9622(84)70195-2
               Oaklander AL, Griffiths PD. Advances in the understanding   13.  Utpat S, Utpat N, Nookala V, Podakula L, Utpat K. Case
               of the pathogenesis and epidemiology of herpes zoster.   report: Hospital-acquired chickenpox in a healthcare
               J Clin Virol. 2010;48 Suppl 1(Suppl 1):S2-S7.      setting. Epidemiol Infect. 2023;152:e3.
               doi: 10.1016/S1386-6532(10)70002-0                 doi: 10.1017/S0950268823001917


            Volume 2 Issue 3 (2025)                         25                               doi: 10.36922/mi.8320
   28   29   30   31   32   33   34   35   36   37   38